Nasdaq · IONS
Ionis Pharmaceuticals, Inc. (IONS)
$44.12+$1.42 (+3.33%)as of 4:00 PM ET Thu 15 Oct
Live quote as of 4:00 PM ET Thu 15 Oct · previous close $42.70 · source: Finnhub
Quarterly revenue
$267.9M
-40.7% vs. a year earlier · Quarter ended 30 Jun 2026
YTD -44.2%1M -1.6%Mkt cap $7.2B52-wk range $42.38–$86.50
What happened
- Ionis Pharmaceuticals closed at $44.12 on Thursday, 15 October, up 3.33%. It is down 44.2% this year, 49.0% below its 52-week closing high.
- Its latest reported quarter (quarter ended 30 Jun 2026) showed revenue of $267.9M, down 40% from $452.0M, and net income of -$114.6M.
- Its most recent 8-K, filed 23 Sep 2026, published a Regulation FD disclosure and disclosed another material event.
- Next earnings: Wednesday, 4 November (estimated date); consensus EPS -$1.20.
IONS price chart
$50$60AugSepOct$44.12
$40$60$80MayJunJulAugSepOct$44.12
$40$60$80NovDecJan '26FebMarAprMayJunJulAugSepOct$44.12
Key numbers
| Revenue (latest quarter) | $267.9M-40.7% year over year · Quarter ended 30 Jun 2026 |
|---|---|
| Revenue (last 4 quarters) | $874.1M |
| Net income | -$114.6Mdown from $123.6M a year earlier |
| Diluted EPS | -$0.69vs. $0.70 a year earlier |
| Operating margin | -38.2% |
| Cash & equivalents | $350.1Mat 30 Jun 2026 |
| Market cap | $7.16BNasdaq |
| 52-week closing range | $42.38 – $86.50high on 6 Feb 2026 |
| Latest periodic report | 10-Qfiled 29 Jul 2026 · period 30 Jun 2026 |
| Next earnings | 4 Nov 2026*estimated (Zacks via Nasdaq) |
| Industry | Biotechnology: Pharmaceutical PreparationsHealth Care |
Revenue by quarter
In the filing
Ionis Pharmaceuticals's latest 10-Q, filed 29 July 2026 for the period ended 30 June 2026, reported revenue of $267.9M, down 40% from $452.0M a year earlier, and 8.9% more than the previous quarter.
Net income was -$114.6M (down from $123.6M). Diluted EPS was -$0.69, against $0.70 a year before. Operating margin was -38.2%. Cash and equivalents stood at $350.1M on 30 Jun 2026.
Latest 8-K · 23 Sep 2026
Ionis Pharmaceuticals published a Regulation FD disclosure and disclosed another material event. Read on SEC.gov
Earnings vs. expectations
Reported EPS Consensus
Recent SEC filings
| Date | Form | What it is |
|---|---|---|
| 23 Sep 2026 | 8-K | Current report: published a Regulation FD disclosure and disclosed another material event |
| 4 Sep 2026 | 8-K | Current report: published a Regulation FD disclosure and disclosed another material event |
| 4 Sep 2026 | 8-K | Current report: published a Regulation FD disclosure and disclosed another material event |
| 29 Jul 2026 | 10-Q | Quarterly report |
| 29 Jul 2026 | 8-K | Current report: reported results of operations |
| 10 Jul 2026 | 8-K | Current report: published a Regulation FD disclosure |
| 9 Jul 2026 | 8-K | Current report: published a Regulation FD disclosure and disclosed another material event |
| 24 Jun 2026 | 8-K | Current report: published a Regulation FD disclosure and disclosed another material event |
The daily filings brief
Before the US open: the movers, the SEC filings and the earnings that matter. Free, one short email per US trading day.
We only use your email to send the brief.